Dutasteride / Hydrocortisone / Minoxidil / Tretinoin (DHMT-Men)

Available Dosage Strengths

0.3% / 1% / 6.5% / 0.01%

Want to Prescribe?

Disclaimer: Images are for reference only; actual products may vary.

Product Overview

This topical solution for men combines dutasteride, hydrocortisone, minoxidil, and tretinoin to effectively combat hair loss by blocking DHT, reducing inflammation, stimulating hair follicles, and enhancing absorption. Each drug has a unique mechanism of action to support development and growth of hair.The synergistic formulation supports visible regrowth, improved hair density, and overall scalp health.

Dutasteride1-3

Dutasteride, a 5-alpha inhibitor, is a 4-azo analog of testosterone. It also has been found to be efficacious for androgenic alopecia, also known as male pattern hair loss.

Hydrocortisone4,5

Hydrocortisone, a steroid hormone that systematically has both glucocorticoid and mineralocorticoid activity, is the synthetic form of cortisol. Cortisol is a hormone produced by the adrenal glands.  Hydrocortisone topically has anti-inflammatory, antipruritic, anti-mitotic, and immunosuppressive properties. There are many topical steroids available on the market. Hydrocortisone is a low potency steroid.

Minoxidil6-8

Topical minoxidil is a vasodilatory compound originally developed as an oral antihypertensive agent. It was found to stimulate hair growth (from the observation of hypertrichosis (excessive, abnormal hair growth) in patients taking oral minoxidil) and was subsequently FDA approved for androgenetic alopecia (male and female pattern hair loss).

Tretinoin9-12

Tretinoin, a naturally occurring derivative of vitamin A, is also called all-trans-retinoic acid. Retinoids may facilitate regulation of cell reproduction, cell proliferation and differentiation. Combing tretinoin and minoxidil may provide a synergistic increase in the expression of hair growth markers (e.g., Erk, Akt, Bcl-2, and Bax).

Dutasteride1-3

Dutasteride is a 4-azo analog of testosterone. It competitively and selectively inhibits both reproductive tissues (type 2) and skin and hepatic (type 1) 5α-reductase. This activity of dutasteride prevents the conversion of testosterone to dihydrotestosterone and significantly suppresses serum dihydrotestosterone levels. The type II 5-alpha-reductase isozyme is primarily found in prostate, seminal vesicles, epididymides, and hair follicles, as well as liver. Dihydrotestosterone has been shown to increase prostate growth and can lead to hair thinning.

Hydrocortisone4,5

The anti-inflammatory effects of topical hydrocortisone may occur through vasoconstriction. The vasoconstriction minimizes inflammatory mediators delivered to the inflamed area. Topical hydrocortisone may also inhibit the release of phospholipase A2, which reduces prostaglandins and leukotriene. Lastly, topical hydrocortisone inhibits DNA and transcription factors related to inflammation. It does this by increasing the expression of anti-inflammatory genes and indirectly inhibit inflammatory transcription factors, such as NF-kB, to decrease the expression of pro-inflammatory genes.

Topical hydrocortisone also has an anti-mitotic effect by decreasing epidermal mitosis mediated through an increase in lipocortin, an endogenous glucocorticoid-regulated protein.

Topical hydrocortisone also inhibits humoral factors in the inflammatory response by suppressing immune cells from maturing, differentiating and proliferating.

Minoxidil6-8

The drug has many mechanisms in supporting hair growth:

  • Potassium channel opening: Minoxidil is a K⁺-ATP channel opener, which may result in vasodilation and enhanced blood flow to hair follicles.
  • Prolongation of the hair cycle: It may extend the growth phase of the hair cycle, leading to increased follicle size and more robust hair shafts.
  • Activation of prostaglandins: May indirectly affect prostaglandin-mediated signaling to stimulate hair follicle activity.
  • Upregulation of vascular endothelial growth factor (VEGF): Promotes angiogenesis in dermal papillae, which may improve follicular nourishment.

Tretinoin9-12

Tretinoin may have several mechanisms to facilitate hair growth including the following:

  • Cell turnover-Tretinoin facilitates skin cell turnover which may open up hair follicles for hair growth
  • Enhanced absorption-Tretinoin may help absorption of minoxidil. This may be from the increased absorption of minoxidil which may be the result of increased sulfonation.
  • Prolong anagen phase-Tretinoin may help lengthen the growth phase of hair follicles.

Dutasteride1-3

Common

  • Scalp pruritus, burning sensation, irritation, contact dermatitis, and erythema

With systematic absorption (rare)

  • Decreased libido
  • Erectile dysfunction
  • Ejaculatory disorders (e.g., reduced volume)
  • Breast tenderness or enlargement
  • Gynecomastia

Hydrocortisone4

Common

  • Skin irritation, pruritus, dry skin, folliculitis, hair growth, acne

 

Minoxidil6-8

Common

Topical minoxidil is generally well tolerated but may cause local effects:

  • Scalp irritation, dryness, flaking
  • Erythema or contact dermatitis (more common with propylene glycol-containing formulations)
  • Pruritus or burning sensation
  • Unwanted facial hair growth (esp. in women or if solution drips onto other areas)

 

Tretinoin9

Common

  • Skin irritation, such as peeling, xerosis (dry skin), burning, stinging, erythema, and pruritus

Contraindications

  • Known hypersensitivity or intolerance to dutasteride, hydrocortisone, latanoprost, minoxidil, and tretinoin or excipients
  • Contraindicated in women who are or may become pregnant if absorbed systemically due to risk of teratogenicity

Precautions

  • Do not apply to open wounds
  • Use cautiously in patients with hepatic dysfunction. The drug is metabolized extensively in the liver.

Store at room temperatures between (59-86°F). Protect from light and keep the container tightly closed. Women should not handle crushed or broken finasteride tablets when they are pregnant or may potentially be pregnant because of the possibility of absorption of finasteride and the subsequent potential risk to a male fetus. Keep out of reach of children and pets.

  1. Dustasterife package insert. January 2020. Accessed August 24, 2025 https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021319s032lbl.pdf
  2. Clinical Pharmacology dutasteride clinical monograph 2025 https://www.clinicalkey.com/pharmacology/  Accessed August, 24, 2025
  3. Al-Horani RA, Patel P. Dutasteride. StatPearls. March 20, 2024. Accessed August 24, 2025. https://www.ncbi.nlm.nih.gov/books/NBK603726/
  4. Clinical Pharmacology hydrocortisone clinical monograph 2025 https://www.clinicalkey.com/pharmacology/     Accessed August 15, 2025
  5. Gabros S, Nessel TA. Topical Corticosteroids. Statpearls. April 26, 2025. Accessed July 27, 2025.
  6. Clinical Pharmacology [Internet].: Elsevier; accessed May 2025; Minoxidil topical monograph. Available from: ClinicalKey; https://www.clinicalkey.com/pharmacology/monograph/408?n=Minoxidil
  7. Rogaine® (minoxidil topical solution) package insert. Johnson & Johnson Consumer Inc. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=12fd18f0-859c-7b9a-e063-6394a90addbf&type=display Revised March 2024. Accessed June 16, 2025
  8. Goren A, Naccarato T. Minoxidil in the treatment of androgenetic alopecia. Dermatol Ther. 2018 Sep;31(5):e12686.
  9. Clinical Pharmacology tretinoin clinical monograph 2025 https://www.clinicalkey.com/pharmacology/
  10. Yoham AL, Casadesus D. Tretinoin. Statpearls. March 27, 2023. Accessed July 27, 2025.
  11. Sharma A, Goren A, Dhurat R, Agrawal S, Sinclair R, Trüeb RM, Vañó-Galván S, Chen G, Tan Y, Kovacevic M, Situm M, McCoy J. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. Dermatol Ther. 2019 May;32(3):e12915.
  12. Can Tretinoin Help with Hair Growth? https://cityskinclinic.com/tretinoin-hair-growth/ June 12, 2025. Accessed August 15, 2025

This information is for educational purposes only. This compounded product has not been reviewed, approved, or evaluated by the Food and Drug Administration for safety and effectiveness. This product is not intended to diagnose, treat, cure, or prevent any disease. No claims are made regarding treatment, cure, or prevention of any disease or condition.

This information may not cover all possible drug information about this product. Call your doctor for medical advice and/or about side effects. You may report side effects to the FDA at 1-800-FDA-1088.  A Wells Pharmacy Network pharmacist will be happy to answer any questions. For consultation, please call 1-800-622-4510.

EXPLORE MORE

Related Medications

We deliver your orders fast and with complete discretion, straight to your door.

We're licensed to ship nationwide

Our mission is to elevate compounding industry standards through a unique combination of superior science and service.

Ready to get started?